Objective: This study aims to estimate the overall prevalence of microvascular complications of type 2 diabetes in mainland China, and to identify any associated risk factors.
Methods: A systematic literature search was conducted to collect the prevalence information of microvascular complications over the past 5 years (2014 -2019) in CNKI, Wanfang, PubMed and the Cochrane Library. A meta-analysis was conducted using R3.4.3 following normal transformations given the skewed raw data. Due to high heterogeneity, a random effect model was selected. A meta-regression analysis was performed to investigate risk factors.
Results: A total of 171 studies were included in the meta-analysis. Of which, 86 studies in diabetic retinopathy, 61 in diabetic nephropathy and 24 in diabetic foot. Results of the meta-analysis showed that the prevalence of diabetic retinopathy was 26.19% [95% CI: 23.02%-29.50%], diabetic nephropathy 27.09% [95% CI: 23.55%-30.79%], and diabetic foot 7.41% [95% CI.5.48%-10.03%], respectively. Duration of type 2 diabetes was identified as the risk factor which was significantly associated with the prevalence of all three microvascular complications (p<0.05).
Conclusion: In mainland China, the prevalence of microvascular complications in patients with type 2 diabetes is high. Early diagnosis and treatment of type 2 diabetes may prevent or delay the development of microvascular complications.
Keywords:
Published on: Jun 5, 2020 Pages: 18-23
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-8583.000042
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."